ArticleFrontiers in oncology2022

Different Radiological Criteria for Early Tumor Response Evaluation in Patients With Unresectable Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody Plus Bevacizumab.

Ying Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.